Gigi Osler

Legislative proposals, bills, and/or resolutions that impact dairy farmers in Manitoba. Regulations relating to compositional standards of dairy products, and those that have impacts on dairy farmers. Promote and defend Canada's supply management system as it relates to trade agreements, bilateral and multilateral negotiations, industry research, and policy changes.

Supporting engagement on the value in curing type one diabetes across Canada by seeking funding for increased and innovative research.

research into blockchain technology in traceability programs, Business risk management programs, Livestock Tax Deferral, Livestock Price Insurance, Agristability, Animal Health programs. Regulations and legislation related to beef cattle and meat production, exports and imports. Market access for beef and cattle, achieving new and defending existing trade agreements. Farm policy and programs with respect to business risk management, innovation, environment, etc. "Taxation policies and programs related to farm income, capital gains, generational transfer of assets, family income sharing, investment income, and tax deferrals for extraordinary revenue due to inventory liquidation during a declared disaster."

Clean electricity regulations and emissions cap Investing in Employment Insurance, care workers, unionized jobs and strong workplace standards Addressing the high cost of living and investing in affordable housing Implementation of universal pharmacare, dental care, long term care and mental health care Labour provisions in the Canada-Ecuador Trade Agreement and Canada-United States-Mexico Agreement. The regularization of undocumented workers, update and possible next steps for the CLC Out-of-status Construction Workers in the GTA project Bill C-65, Canada Elections Act With interest in provisions that impact Third Parties and contributions to Third Parties Bill C-27, Digitial Charter Implementation Act - Part III of C-27 and the impact of artificial intelligence on jobs and workers.

HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH PROMOTION AND DISEASE PREVENTION: Increased investments in health and social-determinants-of-health related programs, including measures to address the opioid crisis, mental health and addictions, and the regulation of natural health products. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, the development of a Federal Disability Benefit, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, providing clarity and guidance on federal forms, and advocacy on discontinuing the requirement that employees present sick notes to their employers. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs. Improve safeguards for Canadian health data. Improve labour mobility so physicians can work across the country. Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key s

Value for physiotherapy in diverse sectors such as primary care. Discussion includes physiotherapy access, expansion of services and scope of practice. Scope of Practice: Physiotherapy scope of practice, skill-set optimization, value for physiotherapy, economic impact. Raise awareness about the role of physiotherapy within a multidisciplinary approach to healthcare and educate policymakers on how physiotherapy can help reduce healthcare costs, maximize current spending and funding allocation through physiotherapy skill optimization, support preventative care and contribute to a healthier Canadian population at all stages of life. Internationally Educated Health Professionals: Monitoring issues related to emerging needs of profession and population. Improving access to safe and effective pain management, such as physiotherapy as a non-pharmacological care, as an upstream and early intervention and prevention response to the opioid crisis Health Human Resource Strategy: Explore opportunities to develop health human resource strategy for the profession of physiotherapy. Discussion includes health human resources planning, health human resource crisis, workforce planning, workforce shortages, scope of practice. Enable support and funding for those communities that could potentially benefit most from telerehabilitation and virtual services, including Indigenous, First Nations, Inuit and Metis and rural and remote populations, where infrastructure may presently exclude them from access (no cellular or internet service/access). Discussion on equity of access to physiotherapy services. Caseload Guidelines: Joint application for funding from Health Canada for Caseload Guidelines development for Physiotherapy, Occupational Therapy. and Speech Language Pathology. Including research regarding physiotherapy specific caseload guidelines. Adult physiotherapy services covered under the Non-Insured Health Benefits program. This includes NHIB, orthotics, medical devices, coverage.

Protect children and youth from online harms by advancing evidence-informed policies (Bill C-34) that promote safer digital environments, support healthy development and well-being, and strengthen protections against harmful online content, interactions, and platform practices. PT stream of the Build Communities Strong Fund, specifically the $5 billion announced specifically for healthcare infrastructure, making sure that children's healthcare needs are taken into account in the program development. Creation of an Indigenous Guiding Circle within Children's Healthcare Canada to provide guidance and counsel on how to better advocate for FNIM children and youth health issues. Protect the Public Health Agency of Canada’s critical work, building confidence in vaccines for children and combatting mis and disinformation influencing decisions impacting children’s health. Protect and expand capacity to deliver on Jordan’s Principle and the Inuit Child First Initiative (a federal responsibility); Top up and broaden the eligibility for the Youth Mental Health Fund, with a focus on prevention, early assessment and rapid intervention in the early years; Include Children’s Priorities in Nation-Building Investments : Asking for capital investments in the children’s healthcare system, including support for research, workforce planning, and the implementation of learning health systems. Advancing a National Children's Strategy to advance child and youth health and well-being outcomes.

World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" World Intellectual Property Organization (WIPO) issues concerning the protection of and access to intellectual property World Health Organization (WHO) issues concerning pharmaceuticals as it relates to Counterfeits, Access to Medicines, and the Intergovernmental Working Group (IGWG) The government's Science and Technology strategy as it relates to the biopharmaceutical industry Subsequent Entry Biologics (SEBs) as it relates to Regulations, Policies, or Guidelines being developed by Health Canada, specifically the Draft Guidance Document on SEBs, the Notices of Changes to Health Canada's Guidance Documents on Data Protection and Patented Medicines Regulations (Notice of Compliance) Regulations Smart Regulations as it relates to the biopharmaceutical industry Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Proposed pharmacare legislation related to any future national pharmacare program Pharmaceutical pricing policy issues arising from the jurisdiction of the Patended Medicines Prices Review Board (PMPRB) Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products New Substances Notification Regulations as it relates to the biopharmaceutical industry Income Tax Act as it relates to biopharmaceutical products Health Canada’s Interim Orders relating to COVID-19: The Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19; The Interim Order Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19; The Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19; The Interim Order Respecting the Prevention and Alleviation of Shortages of Drugs in Relation to Covid-19 Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Free trade treaty agreement as they relate to the North American Free Trade Agreement (NAFTA) and free trade negotiations as it relates to India, the European Union, Japan, MERCOSUR and the Trans-Pacific Partnership Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Establish accountability with the federally financed Canadian Agency for Drugs and Technologies in Health (CADTH) Common Drug Review Policies as it relates to reimbursement recommendation decision-making process and framework Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Canadian Environmental Protection Act and Regulations in respect of modern, science-based regulations to reflect rapidly changing new technologies Canada-United States Regulatory Cooperation Council (RCC) initiatives related to the regulation of biopharmaceutical products Canada's Food and Consumer Safety Action Plan as it relates to the regulation and protection of biopharmaceutical products Canada's Access to Medicines Regime with respect to ensuring that the program allows for the deli

We are lobbying for the protection of farm land and the right to continue to farm with free trade within our country and also with foreign countries.

That the Government of Canada amend the proposed increase to the capital gains tax inclusion rate to except healthcare clinics Raise awareness of the burden of musculoskeletal (MSK) conditions and the need for more strategic approach to management of MSK health for federal populations including Canadian Forces, Veterans, RCMP and First Nations, Metis, and Inuit. Inclusion of chiropractors as recognized qualified practitioners to issue the Disability Tax Credit Certificate(T2201). Improve chiropractic coverage for federal public service employees. Improve access to chiropractic care for Indigenous peoples, particularly by adding coverage for chiropractic services under the Non-Insured Health Benefits Program. Implement the Canadian Pain Task Force's Action Plan for Pain in Canada and enhance the current approach to pain management by improving the integration of non-pharmacological treatments, such as chiropractic care. Expand the Canada Student Loan Forgiveness Program to include front-line allied health care professionals, such as Doctors of Chiropractic. Ensure that the Canadian Armed Forces paid education programs in health care include chiropractic. Ensure that chiropractors are included in the government's plan to introduce a one-time income tax deduction for health care professionals starting their careers in rural communities. Allow refugees and refugee claimants to access chiropractic care under the Interim Federal Health Program (IFHP).